TY  - GEN
AU  - Cohen,A D
AU  - Luger,S M
AU  - Sickles,C
AU  - Mangan,P A
AU  - Porter,D L
AU  - Schuster,S J
AU  - Tsai,D E
AU  - Nasta,S
AU  - Gewirtz,A M
AU  - Stadtmauer,E A
TI  - Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease
SN  - 0268-3369
PY  - 2003///0711
KW  - Acute Disease
KW  - Adolescent
KW  - Adult
KW  - Aminoglycosides
KW  - Anti-Bacterial Agents
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Cause of Death
KW  - Female
KW  - Gemtuzumab
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hepatic Veno-Occlusive Disease
KW  - chemically induced
KW  - Humans
KW  - Immunotoxins
KW  - Incidence
KW  - Leukemia, Myeloid
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Retrospective Studies
KW  - Salvage Therapy
KW  - Therapeutic Equivalency
KW  - Treatment Outcome
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/sj.bmt.1703602
ER  -